Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
455.00    -2.00 (-0.44%)
Bid:
453.00
Ask:
454.00
Spread: 1.00 (0.221%)
Market Cap: £1.24b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Board and Directorate Changes

5 Jun 2025 07:05

RNS Number : 5494L
CMC Markets Plc
05 June 2025
Β 

05 June 2025

CMC Markets plcΒ ("CMC")Β 

Board and Directorate Changes

CMC Markets plc (LON:CMCX) today announces several changes to its Board of Directors and senior leadership team.

Β· David Fineberg, currently Deputy Chief Executive Officer and Board Director, will not stand for re-election at the 2025 Annual General Meeting ("AGM"). He will transition into the newly created role of Global Head of Strategic Partnerships, with a focus on strengthening key institutional relationships and accelerating growth through partnerships such as Revolut and StrikeX.

Β· Matthew Lewis, currently Head of ANZ and Board Director, will also step down from the Board at the 2025 AGM. He will focus fully on expanding the Group's footprint across the ANZ region, particularly in stockbroking and digital asset services.

Β· The Board is pleased to confirm the appointment of Laurence Booth to the Board as an Executive Director, effective 5 June 2025. Laurence will continue in his role as Global Head of Capital Markets, bringing extensive global execution and capital markets expertise to the Board.1

Β· As previously announced, James Richards, Non-Executive Chairman, will step down at the 2025 AGM. James has served on the Board since 2015 and as Chairman since 2018. The Board is pleased to confirm that Paul Wainscott, currently Senior Independent Director, will succeed James as Chairman following the AGM.

The Board would like to express its sincere thanks to David Fineberg and Matthew Lewis for their Board service and looks forward to their continued contributions in their respective leadership roles. The Board also extends its deep gratitude to James Richards for his dedication and leadership over the past decade.

1 There is no other information to be disclosed under UK Listing Rule 6.4.8R (1) to (6) in relation to Laurence Booth.

END

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFIFSIRIIEIIE
Date   Source Headline
6th Dec 202411:49 amRNSDirector/PDMR Shareholding
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.